UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
R R R- R0 R1 R2 R3 R4 RA RB RC RD RE RF RG RH RI RK RM RN RO RP RQ RR RS RT RU RV RW RX RY
selected terms: 2,734 page 1 of 28

1. (-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotic Acid, Hydrochloride
[The hydrochloride salt form of tiagabine, a nipecotic acid derivative with anticonvulsant property. Tiagabine hydrochloride inhibits the gamma-aminobutyric acid (GABA) transporter type 1 (GAT1), which is predominantly localized in presynaptic terminals of neurons thereby preventing the reuptake of GABA by the presynaptic endings. Consequently, this increases the level of available GABA within the synaptic cleft, thereby resulting in prolongation of its inhibitory actions. Tiagabine is effective against maximum electroshock seizures and both limbic and generalized tonic-clonic seizures. ( NCI )] (UMLS (NCI) C0772200) 3-Piperidinecarboxylic Acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-buten-yl)-, Hydrochloride,(R)-;
Tiagabine Hydrochloride;
TIAGABINE HYDROCHLORIDE PREPARATION =Organic Chemical; Pharmacologic Substance =TIAGABINE;
=TIAGABINE HYDROCHLORIDE 12 MG;
TIAGABINE HYDROCHLORIDE 16 MG;
TIAGABINE HYDROCHLORIDE 4 MG;
TIAGABINE HYDROCHLORIDE 2 MG
51. 3RD BRN W LOSS-ABDOM WLL
[ ] (UMLS (ICD9CM) C0375678) =Injury or Poisoning
2. (1R,2R)-2-(2-Carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinolinium Benzenesulfonate, Pentamethylene Ester
[A non-depolarizing skeletal muscle relaxant of the benzylisoquinolinium class. Cisatracurium besylate acts as a competitive acetylcholine antagonist that binds to nicotinic receptors at the neuromuscular junction. Compared to other neuromuscular blocking agents, it is intermediate in its onset and duration of action. Cisatracurium besylate is used to maintain neuromuscular relaxation during major surgical procedures, primarily to facilitate endotracheal intubation. Cisatracurium besylate can cause bronchospasms, hypotension, and bradycardia. ( NCI )] (UMLS (NCI) C0530105) =Organic Chemical; Pharmacologic Substance ;
=Atracurium;
CISATRACURIUM =CISATRACURIUM BESYLATE 10 MG/ML;
CISATRACURIUM BESYLATE 2 MG/ML;
52. 3RD BRN W LOSS-BK OF HND
[ ] (UMLS (ICD9CM) C0161258) =Injury or Poisoning
3. (1R,2S)-(1,2-Epoxypropyl)phosphonic Acid, compound with 2-Amino-2-(hydroxymethyl)-1,3-propanediol(1:1)
[The tromethamine salt form of fosfomycin, a synthetic broad-spectrum antibiotic. Fosfomycin tromethamine binds to and inactivates the enzyme enolpyruvyl transferase. This leads to an irreversible blockage of the condensation of uridine diphosphate-N-acetylglucosamine with p-enolpyruvate, which is one of the first steps of bacterial cell wall synthesis, thereby eventually causing cell lysis. In addition, fosfomycin tromethamine reduces the adherence of bacteria to uroepithelial cells. (NCI05) ( NCI )] (UMLS (NCI) C0543454) =Organophosphorus Compound; Antibiotic ;
=FOSFOMYCIN;
1,3-Propanediol, 2-Amino-2-(hydroxymethyl)- =FOSFOMYCIN TROMETHAMINE 3 GM
53. 3RD BRN W LOSS-CHEST WLL
[ ] (UMLS (ICD9CM) C0161142) =Injury or Poisoning
4. (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,2
[A derivative of the natural macrocyclic lactone sirolimus with immunosuppressant and anti-angiogenic properties. In cells, everolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate an immunosuppressive complex that binds to and inhibits the activation of the mammalian Target of Rapamycin (mTOR), a key regulatory kinase. Inhibition of mTOR activation results in the inhibition of T lymphocyte activation and proliferation associated with antigen and cytokine (IL-2, IL-4, and IL-15) stimulation and the inhibition of antibody production. (NCI05) ( NCI )] (UMLS (NCI) C0541315) =Organic Chemical; Pharmacologic Substance
54. 3RD BRN W LOSS-FNGR/THMB
[ ] (UMLS (ICD9CM) C0161256) =Injury or Poisoning
5. (1R-(1alpha(1R*,2E,4E),3abeta,4E(1R*,3S*,5Z),7aalpha))-5-((1-(6-Ethyl-6-hydroxy-1-methyl-2,4-octadienyl)octahydro-7a-methyl-4H-inden-4-ylidene)ethylidene)-4-methylene-1,3-cyclohexanediol
[A vitamin D3 analogue with potential antineoplastic activity. Seocalcitol binds to and activates the vitamin D receptor, a cytoplasmic polypeptide expressed in normal vitamin D responsive tissues, but also overexpressed in certain cancers including hepatocellular carcinoma and pancreatic cancer. Mediated through vitamin D receptor, this agent induces cancer cell differentiation, inhibits cancer cell growth and induces apoptosis. In addition, seocalcitol may also induce growth arrest and apoptosis independent of vitamin D receptor activation through mechanisms that are not fully elucidated. ( NCI )] (UMLS (NCI) C0905598) 1(S),3(R)-Dihydroxy-20(R)-(5'-ethyl-5'-hydroxyhepta-1'(E),3'(E)-dien-1'-yl)-9,10-secopregna-5(Z),7(E),10(19)-triene;
Seocalcitol =Organic Chemical; Pharmacologic Substance ;
55. 3RD BRN W LOSS-GENITALIA
[ ] (UMLS (ICD9CM) C0375680) =Injury or Poisoning
6. (2'R,3S,3'R,3'aS,6'S,6aS,6bS,7'aR,11aS,11bR)-1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-Octadecahydro-3',6',10,11b-tetramethylspiro[9H-benzo[a]fluorene-9,2'(3'H)-furo[3,2-b
(UMLS (NCI) C0056789) =Organic Chemical ;
56. 3RD BRN W LOSS-HAND NOS
[ ] (UMLS (ICD9CM) C0161252) =Injury or Poisoning
7. (2"R)-4'-O-Tetrahydropyranyladriamycin
[An analogue of the anthracycline antineoplastic antibiotic doxorubicin. Pirarubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. This agent is less cardiotoxic than doxorubicin and exhibits activity against some doxorubicin-resistant cell lines. (NCI04) ( NCI )] (UMLS (NCI) C0071126) =Organic Chemical; Pharmacologic Substance ;
57. 3RD BRN W LOSS-HEAD MULT
[ ] (UMLS (ICD9CM) C0161098) =Injury or Poisoning
8. (2R,3R)-(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol, 2,3-Dihydoxybutanedioate Monohydrate (1:1) (Salt)
[A bitartrate salt of norepinephrine, a synthetic phenylethylamine that mimics the sympathomimetic actions of the endogenous norepinephrine. Norepinephrine bitartrate acts directly on the alpha- and beta-adrenergic receptors. Clinically, norepinephrine is used as a peripheral vasoconstrictor that causes constriction of arterial and venous beds via its alpha-adrenergic action. It is also used as a potent inotropic and chronotropic stimulator of the heart mediated through its beta1 adrenergic action. ( NCI )] (UMLS (NCI) C0028333) =Organic Chemical; Pharmacologic Substance ;
=(.+-.)-Noradrenaline;
=NOREPINEPHRINE BITARTRATE 1 MG/ML;
58. 3RD BRN W LOSS-MULT FNGR
[ ] (UMLS (ICD9CM) C0161255) =Injury or Poisoning
9. (2R,3R,4S)-4-(1,3-Benzodioxo-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic Acid
[A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called endothelin-1 protein receptor antagonists. ( NCI )] (UMLS (NCI) C0935914) ATRASENTAN;
=Organic Chemical; Pharmacologic Substance ;
59. 3RD BRN W LOSS-MULT SITE
[ ] (UMLS (ICD9CM) C0161320) =Injury or Poisoning
10. (2R,3S)-N-Hydroxy-N-[(1S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-(2-methylpropyl)-3-[(2-thienylthio)methyl]butanediamide
[An anticancer drug that belongs to the family of drugs called angiogenesis inhibitors. Batimastat is a matrix metalloproteinase inhibitor. ( NCI )] (UMLS (NCI) C0215791) =Organic Chemical; Pharmacologic Substance ;
60. 3RD BRN W LOSS-TRUNK NEC
[ ] (UMLS (ICD9CM) C0161146) =Injury or Poisoning
11. (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[(3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentad
[semi-synthetic macrolide antibiotic; related to erythromycin. ( CSP )] (UMLS (NCI) C0052796) =Organic Chemical; Antibiotic =macrolide antibiotic;
ERYTHROMYCIN;
[AM200] ERYTHROMYCINS/MACROLIDES;
=AZITHROMYCIN DIHYDRATE;
AZITHROMYCIN 100 MG/5ML;
AZITHROMYCIN 250 MG;
AZITHROMYCIN 200 MG/5ML;
AZITHROMYCIN 600 MG;
AZITHROMYCIN 500 MG;
61. 3RD BRN W LOSS-TRUNK NOS
[ ] (UMLS (ICD9CM) C0161140) =Injury or Poisoning
12. (2R,3S,4S,5E,7S,8S,9R)-2,9- Dihydroxy-3,4;7,8-diepoxy-undeca-5,10-diene
[Depudecin is a fungal metabolite that reverts the rounded phenotype of NIH 3T3 fibroblasts transformed with v-ras and v-src oncogenes to the flattened phenotype of the non-transformed parental cells. The mechanism of de-transformation induced by this agent had not been determined. However, depudecin has been demonstrated to inhibit histone deacetylase (HDAC) activity effectively both in vivo and in vitro. ( NCI )] (UMLS (NCI) C0113086) =Organic Chemical; Biologically Active Substance ;
62. 3RD BRN W LOSS-UPPER ARM
[ ] (UMLS (ICD9CM) C0161196) =Injury or Poisoning
13. (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol
[Lutein (LOO-teen) is a oxygenated carotenoid found in vegetables and fruits. lutein is found in the macula of the eye, where it is believed to act as a yellow filter. Lutein acts as an antioxidant, protecting cells against the damaging effects of free radicals. ( NCI )] (UMLS (NCI) C0043328) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance
63. 3RD BURN W LOSS ARM-MULT
[ ] (UMLS (ICD9CM) C0161200) =Injury or Poisoning
14. (3R,4S,5S,6R)-5-Methoxy-4- [(2R,3R)-2-methyl-3-(3-methyl-2-butenyl) -oxiranyl]-1-oxaspiro [2,5] oct-6-yl(chloroacetyl) Carbamate
(UMLS (NCI) C0081489) =Organic Chemical; Pharmacologic Substance
64. 3RD BURN W LOSS-ARM NOS
[ ] (UMLS (ICD9CM) C0161193) =Injury or Poisoning
15. (3R,5aS,6S,10aR)-2,3,5a,6-Tetrahydro-6-hydroxy-3-(hydroxymethyl)-2-methyl-10H-3,10a-epidithiopyrazino[1,2-a]indole-1,4-dione
[A fungal toxin produced by various species of Trichoderma, Gladiocladium fimbriatum, Aspergillus fumigatus, and Penicillium. It is used as an immunosuppressive agent. ( MSH )] (UMLS (NCI) C0017641) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance
65. 3RD BURN W LOSS-AXILLA
[ ] (UMLS (ICD9CM) C0161197) =Injury or Poisoning
16. (3R,5S,6E)-(+/-)-7-(3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoic Acid
[The sodium salt of a synthetic lipid-lowering agent with potential antineoplastic properties. Fluvastatin competitively inhibits hepatic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. This agent lowers plasma cholesterol and lipoprotein levels, and modulates immune responses through the suppression of MHC II (major histocompatibility complex II) on interferon gamma-stimulated antigen-presenting cells such as human vascular endothelial cells. Due to its anti-inflammatory effects mediated by alterations of lipid metabolism, fluvastatin may possess chemopreventive and therapeutic antineoplastic properties. ( NCI )] (UMLS (NCI) C0246203) =Organic Chemical; Pharmacologic Substance ;
=FLUVASTATIN;
=FLUVASTATIN SODIUM 20 MG;
FLUVASTATIN SODIUM 40 MG;
FLUVASTATIN SODIUM 80 MG
66. 3RD BURN W LOSS-BREAST
[ ] (UMLS (ICD9CM) C0161141) =Injury or Poisoning
17. (6R)-DDATHF
[A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called antifolates. ( NCI )] (UMLS (NCI) C0048852) =Organic Chemical; Pharmacologic Substance ;
67. 3RD BURN W LOSS-ELBOW
[ ] (UMLS (ICD9CM) C0161195) =Injury or Poisoning
18. (6R, 7S)-7-[(R)-2-Amino-2-phenylacetamido]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, Monohydrate
[A semi-synthetic, broad-spectrum, beta-lactamase resistant, second-generation cephalosporin antibiotic derived from cephasporium. The bactericidal activity of loracarbef results from the inhibition of bacterial cell wall synthesis through interference with the cross-linking of peptidoglycan units. This results in a reduction of cell wall stability and causes cell lysis. Loracarbef is more active against a variety of gram-negative organisms but less active against gram-positive pathogens compared to first-generation agents. ( NCI )] (UMLS (NCI) C0065295) =Organic Chemical; Antibiotic ;
=[AM130] BETA-LACTAMS ANTIMICROBIALS, OTHER;
Unclassified Ingredients =LORACARBEF 100 MG/5ML;
LORACARBEF 200 MG;
LORACARBEF 200 MG/5ML;
LORACARBEF 400 MG
68. 3RD BURN W LOSS-FACE NEC
[ ] (UMLS (ICD9CM) C0161096) =Injury or Poisoning
19. (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
[A carboline-based compound with vasodilatory properties. Tadalafil selectively inhibits the cyclic guanosine monophosphate (cGMP)-specific type 5 phosphodiesterase- (PDE-5)-mediated degradation of cGMP, which is found in the smooth muscle of the corpus cavernosa and corpus spongiosum of the penis. Inhibition of cGMP degradation by tadalafil results in prolonged muscle relaxation, vasodilation, and blood engorgement of the corpus cavernosa, thereby prolonged penile erection. ( NCI )] (UMLS (NCI) C1176316) TADALAFIL;
TADALAFIL UNIDENTIFIED =Organic Chemical; Pharmacologic Substance
69. 3RD BURN W LOSS-FINGER
[ ] (UMLS (ICD9CM) C0161253) =Injury or Poisoning
20. (6R,7R)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid
[A beta-lactam antibiotic and first-generation cephalosporin with bactericidal activity. Cefazolin binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. ( NCI )] (UMLS (NCI) C0007546) =Organic Chemical; Antibiotic =Cephalosporanic Acids;
[AM101] CEPHALOSPORINS, 1ST GENERATION =(6R-trans)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)amino)-5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, Sodium Salt
70. 3RD BURN W LOSS-FOREARM
[ ] (UMLS (ICD9CM) C0161194) =Injury or Poisoning
21. (6R,7R)-7-(((2R)-Amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid
[A semi-synthetic, beta-lactam, first-generation cephalosporin antibiotic with bactericidal activity. Cefadroxil binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. PBPs are enzymes involved in the terminal stages of assembling the bacterial cell wall and in reshaping the cell wall during growth and division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. ( NCI )] (UMLS (NCI) C0007538) =Organic Chemical; Antibiotic =cephalexin;
[AM101] CEPHALOSPORINS, 1ST GENERATION =CEFADROXIL MONOHYDRATE;
Cefadroxil 100 MG/ML;
CEFADROXIL 1 GM;
CEFADROXIL 125 MG/5ML;
CEFADROXIL 250 MG/5ML;
CEFADROXIL 500 MG;
71. 3RD BURN W LOSS-HEAD NOS
[ ] (UMLS (ICD9CM) C0161089) =Injury or Poisoning
22. (6R,7R)-7-((R)-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid
[A beta-lactam, first-generation cephalosporin antibiotic with bactericidal activity. Cephradine binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. PBPs participate in the terminal stages of assembling the bacterial cell wall, and in reshaping the cell wall during cell division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. ( NCI )] (UMLS (NCI) C0007738) =Organic Chemical; Antibiotic =cephalexin;
[AM101] CEPHALOSPORINS, 1ST GENERATION =CEPHRADINE 250 MG;
CEPHRADINE 500 MG;
CEPHRADINE 125 MG/5ML;
CEPHRADINE 250 MG/5ML
72. 3RD BURN W LOSS-PALM
[ ] (UMLS (ICD9CM) C0161257) =Injury or Poisoning
23. (6R,7R)-7-(R)-Mandelamido-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-carboxylic Acid
[Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate. ( MSH )] (UMLS (NCI) C0007541) =Organic Chemical; Antibiotic =Cephalosporanic Acids;
[AM102] CEPHALOSPORINS, 2ND GENERATION =CEFOPERAZONE;
Cefamandole Nafate;
(6R-trans)-7-(((2-(Aminomethyl)phenyl)acetyl)amino)-3-(((1-(carboxymethyl)-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid;
Cefamandole Nafate;
73. 3RD BURN W LOSS-SCAPULA
[ ] (UMLS (ICD9CM) C0161199) =Injury or Poisoning
24. (6R,7R,8R,9S,10R,13S,14S,15S,16S,17S)-1,3',4',6,6a,7,8,9,10,11,12,13,14,15,15a,16-Hexadecahydro-10,13-dimethylspiro-(17H-dicyclopropa(6,7:15,16)cyclopenta(a)phenanthrene-17,2'(5'H)-furan)-3,5'(2H)-dione
[A synthetic spironolactone analogue and progestin with progestational and anti-mineralocorticoid activity. Drospirenone binds to the progesterone receptor, the resulting complex becomes activated and binds to specific sites on DNA. This results in a suppression of LH activity and an inhibition of ovulation as well as an alteration in the cervical mucus and endometrium. This leads to an increased difficulty of sperm entry into the uterus and implantation. This drug is used in oral contraceptives. ( NCI )] (UMLS (NCI) C0043822) =Organic Chemical; Pharmacologic Substance ;
=[HS200] CONTRACEPTIVES, SYSTEMIC;
Unclassified Ingredients =DROSPIRENONE 3 MG
74. 3RD BURN W LOSS-SHOULDER
[ ] (UMLS (ICD9CM) C0161198) =Injury or Poisoning
25. (6R-trans)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)amino)-5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, Sodium Salt
[The sodium salt form of cefazolin, a beta-lactam antibiotic and first-generation cephalosporin with bactericidal activity. Cefazolin binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. ( NCI )] (UMLS (NCI) C0700526) =Organic Chemical; Antibiotic =(6R,7R)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid;
=CEFAZOLIN SODIUM 10 GM;
CEFAZOLIN SODIUM 10 MG/ML;
CEFAZOLIN SODIUM 20 GM/VIL;
CEFAZOLIN SODIUM 20 MG/ML;
CEFAZOLIN SODIUM 5 GM/VIL;
CEFAZOLIN SODIUM 1 GM;
CEFAZOLIN SODIUM 500 MG
75. 3RD BURN W LOSS-SITE NOS
[ ] (UMLS (ICD9CM) C0161396) =Injury or Poisoning
26. (6R-trans)-7-(((2-(Aminomethyl)phenyl)acetyl)amino)-3-(((1-(carboxymethyl)-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid
[A semi-synthetic, broad-spectrum, beta-lactam, second-generation cephalosporin antibiotic with bactericidal activity. Ceforanide causes inhibition of bacterial cell wall synthesis by inactivating penicillin binding proteins (PBPs) thereby interfering with the final transpeptidation step required for cross-linking of peptidoglycan units which are a component of the cell wall. This results in a reduction of cell wall stability and causes cell lysis. ( NCI )] (UMLS (NCI) C0055008) =Organic Chemical; Antibiotic ;
=(6R,7R)-7-(R)-Mandelamido-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-carboxylic Acid;
[AM102] CEPHALOSPORINS, 2ND GENERATION;
TO BE DELETED INGREDIENT PREPARATIONS;
76. 3RD BURN W LOSS-THUMB
[ ] (UMLS (ICD9CM) C0161254) =Injury or Poisoning
27. (R)-(4-Oxido-10-oxo-7-palmitoyl-3,5,9-trioxa-4-phosphapentacosyl)trimethylammonium 4-Oxide
[A lung surfactant agent that is used as a replacement for endogenous lung surfactant. Colfosceril palmitate is effective in reducing the surface tension of pulmonary fluids, thereby increasing lung compliance properties to prevent alveolar collapse and improve breathing. This drug is used in the treatment of neonatal respiratory distress. ( NCI )] (UMLS (NCI) C0216971) =Lipid; Pharmacologic Substance ;
=1,2-Dipalmitoylphosphatidylcholine;
COLFOSCERIL =CETYL ALCOHOL/COLFOSCERIL PALMITATE/TYLOXAPOL SUSP,ITRC
77. 3RD BURN W LOSS-WRIST
[ ] (UMLS (ICD9CM) C0161259) =Injury or Poisoning
28. (R)-1-Methyl-4-(1-methylethenyl)cyclohexene
[The dextro isomer of limonene, a natural cyclic monoterpene and major component of the oil extracted from citrus rind with chemo-preventive and antitumor activities. The metabolites of D-limonene, perillic acid, dihydroperillic acid, uroterpenol and limonene 1,2-diol are suggested to inhibit tumor growth through inhibition of p21-dependent signaling, induce apoptosis via the induction of the transforming growth factor beta-signaling pathway, inhibit post-translational modification of signal transduction proteins, result in G1 cell cycle arrest as well as cause differential expression of cell cycle- and apoptosis-related genes. ( NCI )] (UMLS (NCI) C0950252) 1-methyl-4-isopropenyl-1-cyclohexene;
D-Limonene;
LIMONENE, D-;
=Organic Chemical ;
78. 3RD DEG BRN W LOSS-SCALP
[ ] (UMLS (ICD9CM) C0161095) =Injury or Poisoning
29. (R)-2-Fluoro-alpha-methyl[1,1'-biphenyl]-4-acetic Acid
[A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). ( NCI )] (UMLS (NCI) C1327754) R-Flurbiprofen;
=Organic Chemical; Pharmacologic Substance
79. 3RD DEG BURN ABDOMN WALL
[ ] (UMLS (ICD9CM) C0433482) =Injury or Poisoning
30. (R)-3-(2-Deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7, 8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
[adenine nucleotide analog which inhibits adenine deaminase, used as an immunosuppressant to augment antineoplastics. ( CSP )] (UMLS (NCI) C0030896) =Nucleic Acid, Nucleoside, or Nucleotide; Antibiotic ;
=antineoplastic antibiotics;
[AN300] ANTINEOPLASTICS, ANTIMETABOLITES;
Coformycin;
deoxyribonucleoside;
[IM600] IMMUNE SUPPRESSANTS;
nucleoside analog =PENTOSTATIN 10 MG;
80. 3RD DEG BURN ANKLE
[ ] (UMLS (ICD9CM) C0161292) =Injury or Poisoning
31. (R)-4-(3,4-Dihydro-8,8-dimethyl-2H,8H-benzo(1,2-b:3,4-b')dipyran-3-yl)-1,3-benzenediol
(UMLS (NCI) C0664589) =Organic Chemical; Pharmacologic Substance ;
81. 3RD DEG BURN ARM NOS
[ ] (UMLS (ICD9CM) C0161175) =Injury or Poisoning
32. (R)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno(3,2-e)-1,2-thiazine-6-sulfonamide
[A sulfonamide and carbonic anhydrase inhibitor with specific affinity for carbonic anhydrase II. Following topical ocular administration, brinzolamide inhibits carbonic anhydrase II, an enzyme that is responsible for the movement of sodium and fluid transport in the eye. This inhibition leads to a decrease in aqueous humor secretion, probably by slowing the formation of bicarbonate ions, and results in a reduction in intraocular pressure. Brindazolamide is used to treat increased pressure in the eye caused by open-angle glaucoma. ( NCI )] (UMLS (NCI) C0673966) =Organic Chemical; Pharmacologic Substance =azopt;
[OP104] CARBONIC ANHYDRASE INHIBITORS, SYSTEMIC OPHTHALMIC =BRINZOLAMIDE 1 %;
82. 3RD DEG BURN ARM-MULT
[ ] (UMLS (ICD9CM) C0161182) =Injury or Poisoning
33. (R)-6'-Hydroxy-3'-(hydroxymethyl)-2',4',6'-trimethylspiro(cyclopropane-1,5'(5H)-inden)-7'(6'H)-one
[An anticancer drug that belongs to the family of drugs called alkylating agents. Also called irofulven. ( NCI )] (UMLS (NCI) C0532362) =Organic Chemical; Pharmacologic Substance
83. 3RD DEG BURN AXILLA
[ ] (UMLS (ICD9CM) C0274056) =Injury or Poisoning
34. (R)-N-[(5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl]-L-phenylalanine
[A white, crystalline powder that is very unstable in the presence of light but fairly heat resistant. Ochratoxin A is a widespread, naturally occurring mycotoxin that is produced by some fungi, especially by Aspergillus and Penicillium, and is a very common food contaminant found on grains, coffee beans, nuts, decaying vegetation, moldy cereals and animal feeds. This toxin is used in research as an experimental teratogen and carcinogen. Ochratoxin A is reasonably anticipated to be a human carcinogen and may be associated with an increased risk of developing urinary tract tumors. (NCI05) ( NCI )] (UMLS (NCI) C0069299) =Organic Chemical; Pharmacologic Substance ;
84. 3RD DEG BURN BACK
[ ] (UMLS (ICD9CM) C0840810) Full-thickness skin loss due to burn [third degree NOS] of back [any part] =Injury or Poisoning
35. (R,S)-N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino] propyl]tetrahydro-2-furancarboxamide Hydrochloride
[The hydrochloride salt of alfuzosin, a quinazoline compound with smooth muscle-relaxing activity. Alfuzosin selectively binds to and antagonizes post-synaptic alpha-1-adrenoreceptors in smooth muscle of the prostate, bladder base, bladder neck, prostatic capsule, and prostatic urethra, initiating relaxation of smooth muscle and resulting in improvement of urine flow and the symptoms of benign prostatic hyperplasia (BPH). This agent also blocks alpha-1-adrenoreceptors in peripheral vascular smooth muscle, resulting in vasodilatation and a decrease in peripheral vascular resistance. ( NCI )] (UMLS (NCI) C0102130) =Organic Chemical; Pharmacologic Substance ;
85. 3RD DEG BURN BREAST
[ ] (UMLS (ICD9CM) C0433480) =Injury or Poisoning
36. (RS)-11beta,16alpha,17,21,-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal w/ butyraldehyde
[A steroid being studied as an anticancer drug. Budesonide is commonly used to treat asthma and rhinitis. ( NCI )] (UMLS (NCI) C0054201) =Steroid; Pharmacologic Substance =Pregnenediones;
[NT200] ANTI-INFLAMMATORIES, NASAL;
[RE101] ANTI-INFLAMMATORIES, INHALATION;
=Budesonide 0.2 MG/ACTUAT;
BUDESONIDE 3 MG;
BUDESONIDE 0.25 MG/ML;
Budesonide 0.32 MG/ACTUAT;
86. 3RD DEG BURN CHEST WALL
[ ] (UMLS (ICD9CM) C0161126) =Injury or Poisoning
37. *Ranges
[The difference between the lowest and highest numerical values. ( NCI )] (UMLS (HL7) C1514721) Range;
=Quantitative Concept ;
=Kind of quantity;
87. 3RD DEG BURN CHIN
[ ] (UMLS (ICD9CM) C0161071) =Injury or Poisoning
38. *Ratios
(UMLS (HL7) C1610540) =Quantitative Concept =Kind of quantity;
88. 3RD DEG BURN EAR
[ ] (UMLS (ICD9CM) C0161068) =Injury or Poisoning
39. *Reciprocal Relative Time
(UMLS (HL7) C1547038) =Quantitative Concept =Kind of quantity;
89. 3RD DEG BURN ELBOW
[ ] (UMLS (ICD9CM) C0161177) =Injury or Poisoning
40. *Relative
(UMLS (HL7) C1547039) =Quantitative Concept =Kind of quantity;
90. 3RD DEG BURN EYE
[ ] (UMLS (ICD9CM) C0161069) =Injury or Poisoning
41. *Relative Density
(UMLS (HL7) C1576416) =Qualitative Concept =Kind of quantity;
91. 3RD DEG BURN FACE NEC
[ ] (UMLS (ICD9CM) C0161074) =Injury or Poisoning
42. *Relative Mass Concentration
(UMLS (HL7) C1264645) =Quantitative Concept =Kind of quantity;
92. 3RD DEG BURN FINGER
[ ] (UMLS (ICD9CM) C0161233) =Injury or Poisoning
43. *Relative Substance Concentration
(UMLS (HL7) C1264647) =Quantitative Concept =Kind of quantity;
93. 3RD DEG BURN FOOT
[ ] (UMLS (ICD9CM) C0161291) =Injury or Poisoning
44. *Relative Time
(UMLS (HL7) C1547040) =Quantitative Concept =Kind of quantity;
94. 3RD DEG BURN FOREARM
[ ] (UMLS (ICD9CM) C0161176) =Injury or Poisoning
45. 186Re-Etidronate
[A synthetic compound containing the radioisotope rhenium 186 and a chelator, hydroxyethylidene diphosphonate (HEDP). Re-HEDP functions as a bone-seeking radiopharmaceutical when it is mixed with bioactive material, hydroxyapatite (calcium phosphate ceramic) via intravenous infusion. Re-186 is a beta emitter, with a short half life, which provides local effects with limited distribution to extramedullary bone marrow tissues. Re-HEDP can be used to treat pain associated with primary and metastatic bone lesions. ( NCI )] (UMLS (NCI) C0280809) =Organophosphorus Compound; Pharmacologic Substance
95. 3RD DEG BURN GENITALIA
[ ] (UMLS (ICD9CM) C0161129) =Injury or Poisoning
46. 2-Ring Heterocyclic Compound
[A class of organic compounds containing two ring structures, one of which is made up of more than one kind of atom, usually carbon plus another atom. The heterocycle may be either aromatic or nonaromatic. ( NCI )] (UMLS (NCI) C0019400) =Organic Chemical =Heterocyclic Compound;
=benzazepine;
benzimidazole;
benzofuran;
benzopyran;
benzothiadiazine;
Benzoxazoles;
Indazoles;
Indole;
2 benzazine;
Naphthyridines;
pteridine;
purine;
quinazoline;
1 benzazine;
quinolizine;
Quinoxalines;
Bicyclo Compounds, Heterocyclic
96. 3RD DEG BURN HAND NOS
[ ] (UMLS (ICD9CM) C0161232) =Injury or Poisoning
47. 224Ra
[A short-lived, alpha-emitting isotope found in ground water and soils, Radium-224 has been used in biomedical treatments. Radium-224 in drinking water is a potential health risk due to its carcinogenic effects. In the first days after intake, radium heavily concentrates in endosteal bone. Because of the 3.5-day half-life, most Ra-224 decays while on bone surfaces, possibly inducing sarcomas in cells within range of the emitted alpha particles. (NCI04) ( NCI )] (UMLS (NCI) C0076535) =Pharmacologic Substance; Element, Ion, or Isotope ;
97. 3RD DEG BURN HAND-MULT
[ ] (UMLS (ICD9CM) C0161240) =Injury or Poisoning
48. 3-[[(R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]indole, Monohydrobromide
[A triptan with specific affinity for the 5-hydroxytriptamine1B/1D receptor. Eletriptan hydrobromide binds to and acts at serotonin 5-HT1B receptors located on intracranial blood vessels which leads to vasoconstriction. This drug may also exerts its effects by binding to and activating 5-HT 1D receptors on sensory nerve endings in the trigeminal system, which results in the inhibition of pro-inflammatory neuropeptide release. Eletriptan hydrobromide is used to relieve pain or symptoms associated with migraine headaches. ( NCI )] (UMLS (NCI) C1178489) ELETRIPTAN HYDROBROMIDE;
ELETRIPTAN HYDROBROMIDE UNIDENTIFIED =Organic Chemical; Pharmacologic Substance
98. 3RD DEG BURN HEAD NOS
[ ] (UMLS (ICD9CM) C0161067) =Injury or Poisoning
49. 3R,4R,5E,10E,12E,14S,26R,26aS)-26-((2-(Diethylamino)ethyl)sulfonyl)-8,9,14,15,24,25,26,26a-octahydro-14-hydroxy-3-isopropyl-4,12-dimethyl-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone
[A semi-synthetic derivative of streptogramin A produced by streptomycetes. Dalfopristin inhibits the early phase of protein synthesis in the bacterial ribosome by binding to the 70S subunit, and also alters the configuration of the ribosome to make it more susceptible for streptogramin B binding. Dalfopristin is used in combination with quinopristin, a streptogramin B derivative. This combination is active against most gram-positive organisms, including Enterococcus faecium, and is also active against some gram-negative organisms and mycoplasma. ( NCI )] (UMLS (NCI) C0756085) Dalfopristin;
DALFOPRISTIN PREPARATION;
Virginiamycin M1, 26-((2-(diethylamino)ethyl)sulfonyl)-26,27-dihydro-,(26R,27S)-;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance =Mikamycin;
[AM900] ANTI-INFECTIVES, OTHER =DALFOPRISTIN 350 MG;
99. 3RD DEG BURN HEAD-MULT
[ ] (UMLS (ICD9CM) C0161076) =Injury or Poisoning
50. 3RD BRN W LOSS HAND-MULT
[ ] (UMLS (ICD9CM) C0161260) =Injury or Poisoning
100. 3RD DEG BURN KNEE
[ ] (UMLS (ICD9CM) C0161294) =Injury or Poisoning

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.


 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM